Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01815346 · ClinicalTrials.gov registry record · Phase 1
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01815346: Clinical Trial Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT01815346 is a Phase 1 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01815346, a Phase 1 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare the level of effectiveness for 2 acupuncture treatment schedules for chronic CIPN in breast cancer survivors. Researchers also want to study how patients may respond to acupuncture treatments, and how the treatments may affect quality of life, hand function, balance, and the use of drugs for neuropathy pain.
Interventions
- PROCEDURE Acupuncture
- BEHAVIORAL Questionnaires
- OTHER Hand Function and Balance Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-07-06 |
| Est. Completion | 2016-05-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01815346
The ClinicalTrials.gov registry entry for NCT01815346 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acupuncture is the first listed.
NCT01815346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01815346 about?
NCT01815346 is a clinical study titled "Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG". The goal of this clinical research study is to compare the level of effectiveness for 2 acupuncture treatment schedules for chronic CIPN in breast cancer survivors. Researchers also want to study how patients may respond to acupuncture treatments, and how the treatments may affect quality of life, h...
What is the current status of trial NCT01815346?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2014-07-06. Estimated completion is 2016-05-10.
What interventions are being tested in trial NCT01815346?
The interventions under investigation include: Acupuncture (PROCEDURE), Questionnaires (BEHAVIORAL), Hand Function and Balance Tests (OTHER).
Who is sponsoring clinical trial NCT01815346?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.